期刊文献+

慢病毒RNAi载体的制备及滴度测定方法的建立 被引量:2

下载PDF
导出
摘要 目的构建可用于神经系统基因功能研究和基因治疗的慢病毒RNAi载体系统,并建立一种方便、快捷的慢病毒滴度测定方法。方法三质粒系统:PLK0.1-puro、△8.2、水疱性口炎病毒G糖蛋白(VSV-G)共转染293T细胞,产生慢病毒RNAi载体颗粒,超速冷冻离心浓缩;将病毒颗粒进行系列稀释后感染Eca9706细胞,采用嘌呤霉素最小致死量筛选病毒感染细胞的方法,进行慢病毒滴度测定。结果完成了慢病毒RNAi载体的包装及浓缩,确定了嘌呤霉素对Eca9706细胞的最小致死浓度为2.7μg/ml,并应用该浓度测得病毒颗粒的滴度为10^7TU/ml。结论成功构建了一种慢病毒RNAi载体,并建立了一种可行的慢病毒滴度测定方法。
出处 《中原医刊》 2007年第10期32-33,共2页 Central Plains Medical Journal
基金 河南省教育厅自然科学基础研究计划项目资助课题
  • 相关文献

参考文献10

  • 1Bukrinsky MI, Haggerty S, Dempsey MP, et al. A nuclear localization signal within HIV - 1 matrix protein that governs infection of non - dividing cells. Nature, 1993,365:666 - 669.
  • 2Miyoshi H,Smith KA, Mosier DE, et al. Transduetion of human CD34 +cells that mediate long - term engraftment of NOD/SCID mice by HIV vectors. Science, 1999,283:682 - 686.
  • 3Abbas - Terki T, Blanco - Bose W, Deglon N, et al. Lentiviral - mediated RNA interference. Hum Gene Ther, 2002,13 ( 18 ) : 2197 - 2201.
  • 4An DS, Xie Y, Mao SH, et al. Efficient lentiviral vectors for short hairpin RNA delivery into human cells. Hum Gene Ther,2003,14(12) :1207 - 1212.
  • 5Anthony RV,Cantlon JD. RNA Interference:a new approach to the in vivo study of gene function. J Anim Sci,2007,85 :E18 - E19.
  • 6Abbas - Terki T, Blanco - Bose W, Deglon N, et al. Lentiviral - mediated RNA interference. Hum Gene Ther,2002,13 (18 ) :2197 -2201.
  • 7Naldini L, Blomer U, Gage FH, et al. Efficient transfer, integration, and sustained long - term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci USA, 1996,93:11382-11388.
  • 8Buchschacher GL Jr,Wong - Staal F. Development of lentiviral vectors for gene therapy for human diseases. Blood ,2000,95 (8) :2499 - 2504.
  • 9Delenda C, Gaillard C. Real - time quantitative PCR for the design of lentiviral vector analytical assays. Gene Ther,2005,12 :S36 -S50.
  • 10Martine Geraerts,Sofie Willems, Veerle Baekelandt, et al. Comparison of lentiviral vector titration methods. BMC Biotechnology,2006,6:34.

同被引文献18

  • 1Salmon P, Trono D. Production and titration of lentiviral vectors. Curr Protoc Hum (3enet 2007, Chapter 4, unit4.21.
  • 2Naldini L. Lentiviruses as gene transfer agents for delivery to non-dividing cells. Curr Opin Biot 1998; 9(5): 457-63.
  • 3Naldini L BU, Gallay P, Ory D, Mulligan R, Gage FH, Verma IM, Trono D. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 1996; 272: 263- 7.
  • 4Naldini L, Blomer U, Gage FH, Trono D, Verma IM. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci USA 1996; 93(21): 11381-8.
  • 5Buchschaeher GL, Wong-Staal F. Development of lentiviral vectors for gene therapy for human diseases. Blood 2000; 95(8): 2499-504.
  • 6Geraerts M, Willems S, Baekelandt V, Debyser Z, Gijsbers R. Comparison of lentiviral vector titration methods. BMC Biotech- no12006; 6: 34.
  • 7Kutner RH, Zhang XY, Reiser J. Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors. Nat Pro- toc 2009; 4(4): 495-505.
  • 8Geraerts M, Michiels M, Baekelandt V, Debyser Z, Gijsbers R. Upscaling of lentiviral vector production by tangential flow fil- tration. J Gene Med 2005; 7(10): 1299-310.
  • 9Bukrinsky MI, Haggerty S, Dempsey MP, Sharova N, Adzhubel A, Spitz L, et al. A nuclear localization signal within HIV- 1 ma- trix protein that governs infection of non-dividing cells. Nature 1993; 365(6447): 666-9.
  • 10Logan AC, Nightingale S J, Haas DL, Cho G J, Pepper KA, Kohn DB. Factors influencing the titer and infectivity of lentiviral vec- tors. Human Gene Therapy 2004; 15(10): 976-88.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部